QUANTA THERAPEUTICS
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
QUANTA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2018-01-01
Address:
San Francisco, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
60 M USD
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series C - Quanta Therapeutics
Longitude Capital
Longitude Capital investment in Series C - Quanta Therapeutics
Logos Capital
Logos Capital investment in Series C - Quanta Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series C - Quanta Therapeutics
Vida Ventures
Vida Ventures investment in Series C - Quanta Therapeutics
BVF Partners
BVF Partners investment in Series C - Quanta Therapeutics
Surveyor Capital
Surveyor Capital investment in Series C - Quanta Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Quanta Therapeutics